ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy

Lin, Enyu; Zhu, Ping; Ye, Chujin; Huang, ManLi; Liu, Xuechao; Tian, Kaiwen; Tang, Yanlin; Zeng, Jiayi; Cheng, Shouyu; Liu, Jiumin; Liu, Yanjun*; Yu, Yuming*广东省人民医院; 南方医科大学; 青岛大学; 汕头大学; 中国医科大学
Frontiers in Immunology2022-5-23DOI: 10.3389/fimmu.2022.830220
5被引8阅读
引用收藏
分享

摘要

Unlike early clear cell renal cell carcinoma (ccRCC), locally advanced and metastatic ccRCC present poor treatment outcomes and prognosis. As immune checkpoint inhibitors have achieved favorable results in the adjuvant treatment of metastatic ccRCC, we aimed to investigate the immunogenomic landscape during ccRCC progression and its potential impact on immunotherapy and prognosis. Using multi-omics and immunotherapy ccRCC datasets, an integrated analysis was performed to identify genomic alterations, immune microenvironment features, and related biological processes during ccRCC progression and evaluate their relevance to immunotherapy response and prognosis. We found that aggressive and metastatic ccRCC had higher proportions of genomic alterations, including SETD2 mutations, Del(14q), Del(9p), and higher immunosuppressive cellular and molecular infiltration levels. Of these, the Del(14q) might mediate immune escape in ccRCC via the VEGFA-VEGFR2 signaling pathway. Furthermore, immune-related pathways associated with ccRCC progression did not affect the immunotherapeutic response to ccRCC. Conversely, cell cycle pathways not only affected ccRCC progression and prognosis, but also were related to ccRCC immunotherapeutic response resistance. Overall, we described the immunogenomic characteristics of ccRCC progression and their correlations with immunotherapeutic response and prognosis, providing new insights into their prediction and the development of novel therapeutic strategies.

学科与关键词

关键词
clear cell renal cell carcinoma (ccRCC)genomic alterationtumor immune microenvironmentimmunotherapymulti-omics analysis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-05-23
卷期
第 13 卷
页码
830220
DOI
10.3389/fimmu.2022.830220
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Science and Technology Project of Guangzhou [202002030060]; Guangdong Basic and Applied Basic Research Foundation [2020A1515011473]; National Natural Science Foundation of China [82002528]

作者

  • L

    Lin, Enyu (第一作者)

    shantou univ · guangdong prov peoples hosp

  • Z

    Zhu, Ping

    southern med univ

查看全部 12 位作者收起作者
  • Y

    Ye, Chujin

    guangdong prov peoples hosp

  • H

    Huang, ManLi

  • L

    Liu, Xuechao

    qingdao univ

  • T

    Tian, Kaiwen

    guangdong prov peoples hosp

  • T

    Tang, Yanlin

    shantou univ · guangdong prov peoples hosp

  • Z

    Zeng, Jiayi

    guangdong prov peoples hosp

  • C

    Cheng, Shouyu

    guangdong prov peoples hosp

  • L

    Liu, Jiumin

    guangdong prov peoples hosp

  • L

    Liu, Yanjun (通讯)

    southern med univ

  • Y

    Yu, Yuming (通讯)

    2 · southern med univ · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417